Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease
Inflammatory bowel disease (IBD) is a special chronic intestinal inflammatory disease, which is mainly divided into Crohn's disease (CD) and ulcerative colitis (UC). Its occurrence is a complex process that regulated by multiple signaling pathways, including nuclear factor erythroid 2-related f...
Main Authors: | Botong Li, Yixuan Wang, Xiaolin Jiang, Hongwei Du, Yan Shi, Minghui Xiu, Yongqi Liu, Jianzheng He |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223007400 |
Similar Items
-
Using Drosophila melanogaster as a suitable platform for drug discovery from natural products in inflammatory bowel disease
by: Minghui Xiu, et al.
Published: (2022-12-01) -
Protective effect of astragalus membranaceus and its bioactive compounds against the intestinal inflammation in Drosophila
by: Jianzheng He, et al.
Published: (2022-12-01) -
The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy
by: Shuo Yuan, et al.
Published: (2023-09-01) -
Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease
by: Samuel Fernández-Tomé, et al.
Published: (2021-09-01) -
Activation of Nrf2 by Natural Bioactive Compounds: A Promising Approach for Stroke?
by: Agnese Gugliandolo, et al.
Published: (2020-07-01)